Research ArticleWorkshops and Special Sessions
Open Access

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016

Ana-Maria Orbai, Maarten de Wit, Philip J. Mease, Kristina Callis Duffin, Musaab Elmamoun, William Tillett, Willemina Campbell, Oliver FitzGerald, Dafna D. Gladman, Niti Goel, Laure Gossec, Pil Hoejgaard, Ying Ying Leung, Chris Lindsay, Vibeke Strand, Désirée M. van der Heijde, Bev Shea, Robin Christensen, Laura Coates, Lihi Eder, Neil McHugh, Umut Kalyoncu, Ingrid Steinkoenig and Alexis Ogdie
The Journal of Rheumatology October 2017, 44 (10) 1522-1528; DOI: https://doi.org/10.3899/jrheum.160904

REFERENCES

  1. 1.↵
    1. Tunis SR,
    2. Clarke M,
    3. Gorst SL,
    4. Gargon E,
    5. Blazeby JM,
    6. Altman DG,
    7. et al.
    Improving the relevance and consistency of outcomes in comparative effectiveness research. J Comp Eff Res 2016;5:193–205.
    OpenUrl
  2. 2.↵
    1. Boers M,
    2. Brooks P,
    3. Strand CV,
    4. Tugwell P
    . The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol 1998;25:198–9.
    OpenUrlPubMed
  3. 3.↵
    1. Boers M,
    2. Kirwan J,
    3. Tugwell P,
    4. Beaton D,
    5. Bingham CO 3rd,
    6. Conaghan PG,
    7. et al.
    The OMERACT Handbook. OMERACT; 2014.
  4. 4.↵
    1. Gladman DD,
    2. Mease PJ,
    3. Strand V,
    4. Healy P,
    5. Helliwell PS,
    6. Fitzgerald O,
    7. et al.
    Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167–70.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Boers M,
    2. Kirwan JR,
    3. Wells G,
    4. Beaton D,
    5. Gossec L,
    6. d’Agostino MA,
    7. et al.
    Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745–53.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Coates LC,
    2. Kavanaugh A,
    3. Mease PJ,
    4. Soriano ER,
    5. Laura Acosta-Felquer M,
    6. Armstrong AW,
    7. et al.
    Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheumatol 2016;68:1060–71.
    OpenUrl
  7. 7.↵
    1. Kirwan JR,
    2. de Wit MP,
    3. Bingham CO 3rd,
    4. Leong A,
    5. Richards P,
    6. Tugwell P,
    7. et al;
    8. Outcome Measures in Rheumatology Executive Committee
    . Commentary: Patients as partners: building on the experience of outcome measures in rheumatology. Arthritis Rheumatol 2016;68:1334–6.
    OpenUrl
  8. 8.↵
    1. Tillett W,
    2. Eder L,
    3. Goel N,
    4. De Wit M,
    5. Gladman DD,
    6. FitzGerald O,
    7. et al.
    Enhanced patient involvement and the need to revise the core set - report from the Psoriatic Arthritis Working Group at OMERACT 2014. J Rheumatol 2015;42:2198–203.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Orbai AM,
    2. Mease PJ,
    3. de Wit M,
    4. Kalyoncu U,
    5. Campbell W,
    6. Tillett W,
    7. et al.
    Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. J Rheumatol 2016;43:965–9.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Kalyoncu U,
    2. Ogdie A,
    3. Campbell W,
    4. Bingham CO 3rd,
    5. de Wit M,
    6. Gladman DD,
    7. et al.
    Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. RMD Open 2016;2:e000217.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Orbai AM,
    2. de Wit M,
    3. Mease P,
    4. Shea JA,
    5. Gossec L,
    6. Leung YY,
    7. et al.
    International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis 2016 Sep 9 (E-pub ahead of print).
  12. 12.↵
    1. Palominos PE,
    2. Gaujoux-Viala C,
    3. Fautrel B,
    4. Dougados M,
    5. Gossec L
    . Clinical outcomes in psoriatic arthritis: a systematic literature review. Arthritis Care Res 2012;64:397–406.
    OpenUrlCrossRef
  13. 13.↵
    1. Gossec L,
    2. de Wit M,
    3. Kiltz U,
    4. Braun J,
    5. Kalyoncu U,
    6. Scrivo R,
    7. et al;
    8. EULAR PsAID Taskforce
    . A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 2014;73:1012–9.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Walsh JA,
    2. McFadden ML,
    3. Morgan MD,
    4. Sawitzke AD,
    5. Duffin KC,
    6. Krueger GG,
    7. et al.
    Work productivity loss and fatigue in psoriatic arthritis. J Rheumatol 2014;41:1670–4.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Gudu T,
    2. Etcheto A,
    3. de Wit M,
    4. Heiberg T,
    5. Maccarone M,
    6. Balanescu A,
    7. et al.
    Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. Joint Bone Spine 2016;83:439–43.
    OpenUrl
  16. 16.↵
    1. Healy PJ,
    2. Helliwell PS
    . Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol 2007;34:1302–6.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Keeley T,
    2. Williamson P,
    3. Callery P,
    4. Jones LL,
    5. Mathers J,
    6. Jones J,
    7. et al.
    The use of qualitative methods to inform Delphi surveys in core outcome set development. Trials 2016;17:230.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Van de Ven AH,
    2. Delbecq AL
    . The nominal group as a research instrument for exploratory health studies. Am J Public Health 1972;62:337–42.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. World Health Organization
    . Towards a common language for functioning, disability and health ICF. Geneva: World Health Organization; 2002:9–10.
  20. 20.↵
    1. Tillett W,
    2. de-Vries C,
    3. McHugh NJ
    . Work disability in psoriatic arthritis: a systematic review. Rheumatology 2012;51:275–83.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Kavanaugh A,
    2. Gladman D,
    3. van der Heijde D,
    4. Purcaru O,
    5. Mease PJ
    . Clinical responses in joint and skin outcomes and patient-reported outcomes are associated with increased productivity in the workplace and at home in psoriatic arthritis patients treated with certolizumab pegol. Value Health 2015;18:A654.
    OpenUrl
  22. 22.↵
    1. Ogdie A,
    2. Schwartzman S,
    3. Husni ME
    . Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 2015;27:118–26.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Orbai AM,
    2. Ogdie A
    . Patient-reported outcomes in psoriatic arthritis. Rheum Dis Clin North Am 2016;42:265–83.
    OpenUrl
  24. 24.↵
    1. Beaton DE,
    2. Terwee CB,
    3. Singh JA,
    4. Hawker GA,
    5. Patrick DL,
    6. Burke LB,
    7. et al.
    A call for evidence-based decision making when selecting outcome measurement instruments for summary of findings tables in systematic reviews: results from an OMERACT Working Group. J Rheumatol 2015;42:1954–61.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

PSORIATIC ARTHRITIS
CORE SET
OUTCOME MEASURES

Keywords